The lack of effect of phenol red or estradiol on the growth response of human, rat, and mouse mammary cells in primary culture.
Normal and neoplastic mammary cells from both human and rodent sources grow in culture in response to a number of hormones and growth factors. However, with the exception of a few human tumor lines, a consistent growth-promoting effect of estrogens on mammary cells has not been observed. Mammary cells can be shown to respond to other hormones and factors, such as PRL, hydrocortisone, and epidermal growth factor. Recent observations suggest that the pH indicator dye phenol red, found in most media, may be masking any exogenous estrogenic effects by acting as a weak estrogen. To test this possibility, we reexamined the effects of estradiol (E2) and the antiestrogen keoxifene on the growth of normal human, mouse, and rat mammary cells in the absence of phenol red. Primary cultures of these mammary cells were grown within a rat tail collagen gel matrix in a serum-free medium made up of Ham's F-12 and Dulbecco's Modified Eagles' medium (1:1) with and without phenol red. The medium was supplemented with various hormones and growth factors. These supplements were selected for each cell type to produce a variety of conditions from nongrowing to rapidly growing. The effects of E2 (10(-10)-10(-8) M, keoxifene (10(-9)-10(-6) M), and phenol red on growth under these various conditions were examined. Phenol red had no effect on growth, and its absence did not restore a response to E2. Keoxifene, in the presence or absence of E2, also had no effect on growth. Although E2 had no effect on growth, it was able to induce a 150% increase in the progesterone receptor levels in normal mouse mammary cells in culture, indicating that the cells retain their capacity to respond to E2. This work supports the idea that the effect of estrogens on growth in vivo may be mediated through some other factor(s).
Richards
J
J
Cancer Research Laboratory, University of California, Berkeley 94720.
Imagawa
W
W
Balakrishnan
A
A
Edery
M
M
Nandi
S
S
D000818:Animals; D001940:Breast / Q000166:cytology / Q000187:drug effects*; D001943:Breast Neoplasms / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D006801:Humans; D007700:Kinetics; D008321:Mammary Glands, Animal / Q000166:cytology / Q000187:drug effects*; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010635:Phenolphthaleins / Q000494:pharmacology*; D010637:Phenolsulfonphthalein / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D020849:Raloxifene Hydrochloride; D051381:Rats; D011917:Rats, Inbred Lew; D011980:Receptors, Progesterone / Q000378:metabolism; D013045:Species Specificity; D014407:Tumor Cells, Cultured
D004965:Estrogen Antagonists; D010635:Phenolphthaleins; D010880:Piperidines; D011980:Receptors, Progesterone; D020849:Raloxifene Hydrochloride; D004958:Estradiol; D004815:Epidermal Growth Factor; D011388:Prolactin; D010637:Phenolsulfonphthalein